AN2 Therapeutics, Inc. - Common Stock (NQ: ANTX )
1.140
+0.040
(+3.64%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 26, 2024
Add to My Watchlist
All News about AN2 Therapeutics, Inc. - Common Stock
![](https://mms.businesswire.com/media/20240816585924/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan
August 16, 2024
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2024/08/15/penny-stocks-tips-1.jpeg?width=1200&height=800&fit=crop)
Citizens And 2 Other Penny Stocks Insiders Are Buying
August 15, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240813783660/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/08/09/oil-ai.png?width=1200&height=800&fit=crop)
Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results
August 09, 2024
Via Benzinga
Exposures
Fossil Fuels
![](https://investorplace.com/wp-content/uploads/2020/02/medicine-iv-drip.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/08/09/wall-street-chart-shutter2.jpeg?width=1200&height=800&fit=crop)
US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results
August 09, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/08/09/ANTX.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-pre-market.jpg)
![](https://mms.businesswire.com/media/20240808125351/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240514775764/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://mms.businesswire.com/media/20240328333538/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/02/13/zoominfo_technologies_-_logo_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/12/image45.jpg?width=1200&height=800&fit=crop)
Nasdaq Edges Lower; ContextLogic Shares Surge
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/02/12/big_lots_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Intraday Session
February 12, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/02/12/image39.jpeg?width=1200&height=800&fit=crop)
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/02/12/image44_0.jpg?width=1200&height=800&fit=crop)
US Stocks Mixed; Trimble Issues Weak Outlook
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2024/laboratory-563423-1280_0.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/02/12/monday.com_-_logo.jpg?width=1200&height=800&fit=crop)
Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 12, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240212430072/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20240130626235/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20231109308786/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
![](https://mms.businesswire.com/media/20231106781305/en/1863965/5/AN2_Therapeutics_Press_Release_Logo.jpg)
AN2 Therapeutics to Present at Upcoming Investor Conferences
November 06, 2023
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.